glp-1 drugs competitive intelligence 2025 Outlook for obesity in 2025: more than a transition year GLP-1 Agonists Market Report 2025-2033,

Niacinamide: Helps visibly improve uneven tone while supporting a calm and balanced surface

Clinical Applications PT-141 is commonly used for: Male sexual dysfunction (with or without ED) Female sexual arousal disorder (FSAD) and hypoactive sexual desire disorder (HSDD) Loss of libido due to menopause, antidepressants, or stress Enhancement of sexual confidence and spontaneity Adjunct to testosterone therapy or HRT It has demonstrated success in both pre-menopausal and post-menopausal women , as well as in men who do not fully respond to PDE5 inhibitors

The pathogenesis of NAFLD is multifactorial and only partially understood (46)

Full text: Stein, J., Geisel, J., & Obeid, R

Chen H, Li J, Li N, Liu H, Tang J

Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells